Abstract
To determine if lower rubella susceptibility persisted five to seven years after immunization legislation, we retrospectively reviewed the serologic status of 341 outpatients from 1985 to 1987 in an inner-city school age population. Seronegative rates increased significantly during the two-year study period from 4.2 to 24.5 percent (17 percent overall). (Beta = 6.8%, 95% CI = 3.3, 10.3). Charts were reviewed for 57 of 58 seronegative and 114 seropositive controls. Estimates were then made to the population of 341 subjects. Those with documented rubella immunization had a seronegative rate of 13 percent compared to 19 percent if the immunization status was unknown. For patients who received care in our clinic for less than two years, 32 percent were seronegative compared to 10 percent for those treated greater than or equal to 2 years (odds ratio = 0.31, 95% CI = 0.16, 0.60). Among patients immunized in 1977 or 1978, 33 percent were seronegative compared to 7 percent immunized at other times (OR = 0.21, 95% CI = 0.07, 0.63). Factors associated with increased rubella seronegativity include immunization in 1977 or 1978 and lack of continuity of care in our clinic. Much of the increase remains unexplained.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bart K. J., Orenstein W. A., Preblud S. R., Hinman A. R., Lewis F. L., Jr, Williams N. M. Elimination of rubella and congenital rubella from the United States. Pediatr Infect Dis. 1985 Jan-Feb;4(1):14–21. doi: 10.1097/00006454-198501000-00006. [DOI] [PubMed] [Google Scholar]
- Chu S. Y., Bernier R. H., Stewart J. A., Herrmann K. L., Greenspan J. R., Henderson A. K., Liang A. P. Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands. JAMA. 1988 Jun 3;259(21):3133–3136. doi: 10.1001/jama.259.21.3133. [DOI] [PubMed] [Google Scholar]
- Dales L. G., Chin J. Public health implications of rubella antibody levels in California. Am J Public Health. 1982 Feb;72(2):167–172. doi: 10.2105/ajph.72.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herrmann K. L. Available rubella serologic tests. Rev Infect Dis. 1985 Mar-Apr;7 (Suppl 1):S108–S112. doi: 10.1093/clinids/7.supplement_1.s108. [DOI] [PubMed] [Google Scholar]
- Herrmann K. L., Halstead S. B., Wiebenga N. H. Rubella antibody persistence after immunization. JAMA. 1982 Jan 8;247(2):193–196. [PubMed] [Google Scholar]
- Hillary I. B., Griffith A. H. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine. Br Med J. 1980 Jun 28;280(6231):1580–1581. doi: 10.1136/bmj.280.6231.1580-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Krugman R. D., Meyer B. C., Enterline J. C., Parkman P. D., Witte J. J., Meyer H. M., Jr Impotency of live-virus vaccines as a result of improper handling in clinical practice. J Pediatr. 1974 Oct;85(4):512–514. doi: 10.1016/s0022-3476(74)80455-5. [DOI] [PubMed] [Google Scholar]
- Lawless M. R., Abramson J. S., Harlan J. E., Kelsey D. S. Rubella susceptibility in sixth graders: effectiveness of current immunization practice. Pediatrics. 1980 Jun;65(6):1086–1089. [PubMed] [Google Scholar]
- Lerman S. J., Gold E. Measles in children previously vaccinated against measles. JAMA. 1971 May 24;216(8):1311–1314. [PubMed] [Google Scholar]
- McLaughlin M. C., Gold L. H. The New York rubella incident: a case for changing hospital policy regarding rubella testing and immunization. Am J Public Health. 1979 Mar;69(3):287–289. doi: 10.2105/ajph.69.3.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller K. A., Zager T. D. Rubella susceptibility in an adolescent female population. Mayo Clin Proc. 1984 Jan;59(1):31–34. doi: 10.1016/s0025-6196(12)60339-5. [DOI] [PubMed] [Google Scholar]
- Nelson D. B., Layde M. M., Chatton T. B. Rubella susceptibility in inner-city adolescents: the effect of a school immunization law. Am J Public Health. 1982 Jul;72(7):710–713. doi: 10.2105/ajph.72.7.710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Shea S., Best J. M., Banatvala J. E., Marshall W. C., Dudgeon J. A. Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) 1982 Jul 24;285(6337):253–255. doi: 10.1136/bmj.285.6337.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Orenstein W. A., Herrmann K. L., Holmgreen P., Bernier R., Bart K. J., Eddins D. L., Fiumara N. J. Prevalence of rubella antibodies in Massachusetts schoolchildren. Am J Epidemiol. 1986 Aug;124(2):290–298. doi: 10.1093/oxfordjournals.aje.a114387. [DOI] [PubMed] [Google Scholar]
- Polk B. F., White J. A., DeGirolami P. C., Modlin J. F. An outbreak of rubella among hospital personnel. N Engl J Med. 1980 Sep 4;303(10):541–545. doi: 10.1056/NEJM198009043031001. [DOI] [PubMed] [Google Scholar]
- Serdula M. K., Halstead S. B., Wiebenga N. H., Herrmann K. L. Serological response to rubella revaccination. JAMA. 1984 Apr 20;251(15):1974–1977. [PubMed] [Google Scholar]
- Skendzel L. P. Current status of rubella testing: a report based on data from the College of American Pathologists' surveys, 1978-1980. Am J Clin Pathol. 1981 Oct;76(4 Suppl):547–553. [PubMed] [Google Scholar]
- Storch G. A., Myers N. Latex-agglutination test for rubella antibody: validity of positive results assessed by response to immunization and comparison with other tests. J Infect Dis. 1984 Mar;149(3):459–464. doi: 10.1093/infdis/149.3.459. [DOI] [PubMed] [Google Scholar]
- Wilkins J., Wehrle P. F. Further evaluation of the optimum age for rubella vaccine administration. Am J Dis Child. 1979 Dec;133(12):1237–1239. doi: 10.1001/archpedi.1979.02130120029004. [DOI] [PubMed] [Google Scholar]
